162 related articles for article (PubMed ID: 9806565)
1. Prevention of severe ovarian hyperstimulation by coasting.
Dhont M; Van der Straeten F; De Sutter P
Fertil Steril; 1998 Nov; 70(5):847-50. PubMed ID: 9806565
[TBL] [Abstract][Full Text] [Related]
2. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
3. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
4. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome.
Benadiva CA; Davis O; Kligman I; Moomjy M; Liu HC; Rosenwaks Z
Fertil Steril; 1997 Apr; 67(4):724-7. PubMed ID: 9093201
[TBL] [Abstract][Full Text] [Related]
5. Comparison of coasting and intravenous albumin in the prevention of ovarian hyperstimulation syndrome.
Chen CD; Chao KH; Yang JH; Chen SU; Ho HN; Yang YS
Fertil Steril; 2003 Jul; 80(1):86-90. PubMed ID: 12849806
[TBL] [Abstract][Full Text] [Related]
6. Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study.
Egbase PE; Sharhan MA; Grudzinskas JG
Hum Reprod; 1999 Jun; 14(6):1421-5. PubMed ID: 10357951
[TBL] [Abstract][Full Text] [Related]
7. "Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients.
Tortoriello DV; McGovern PG; Colón JM; Skurnick JH; Lipetz K; Santoro N
Fertil Steril; 1998 Mar; 69(3):454-60. PubMed ID: 9531876
[TBL] [Abstract][Full Text] [Related]
8. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
Mansour R; Aboulghar M; Serour G; Amin Y; Abou-Setta AM
Hum Reprod; 2005 Nov; 20(11):3167-72. PubMed ID: 16006465
[TBL] [Abstract][Full Text] [Related]
9. Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.
Esinler I; Bozdag G; Karakocsokmensuer L
Arch Gynecol Obstet; 2013 Nov; 288(5):1159-63. PubMed ID: 23677417
[TBL] [Abstract][Full Text] [Related]
10. Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.
Bushaqer NJ; Dayoub NM; AlHattali KK; Ayyoub HA; AlFaraj SS; Hassan SN
Saudi Med J; 2018 Mar; 39(3):290-295. PubMed ID: 29543308
[TBL] [Abstract][Full Text] [Related]
11. Correctly timed coasting reduces the risk of ovarian hyperstimulation syndrome and gives good cycle outcome in an in vitro fertilization program.
Grochowski D; Wołczyński S; Kuczyński W; Domitrz J; Szamatowicz J; Szamatowicz M
Gynecol Endocrinol; 2001 Jun; 15(3):234-8. PubMed ID: 11447736
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.
Griesinger G; Verweij PJ; Gates D; Devroey P; Gordon K; Stegmann BJ; Tarlatzis BC
PLoS One; 2016; 11(3):e0149615. PubMed ID: 26950065
[TBL] [Abstract][Full Text] [Related]
13. Coasting-what is the best formula?
Levinsohn-Tavor O; Friedler S; Schachter M; Raziel A; Strassburger D; Ron-El R
Hum Reprod; 2003 May; 18(5):937-40. PubMed ID: 12721165
[TBL] [Abstract][Full Text] [Related]
14. Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients.
Al-Shawaf T; Zosmer A; Hussain S; Tozer A; Panay N; Wilson C; Lower AM; Grudzinskas JG
Hum Reprod; 2001 Jan; 16(1):24-30. PubMed ID: 11139531
[TBL] [Abstract][Full Text] [Related]
15. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
Farhi J; Ben-Haroush A; Lande Y; Sapir O; Pinkas H; Fisch B
Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
[TBL] [Abstract][Full Text] [Related]
16. Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome.
Delvigne A; Kostyla K; Murillo D; Van Hoeck J; Rozenberg S
Int J Fertil Womens Med; 2003; 48(1):25-31. PubMed ID: 12643517
[TBL] [Abstract][Full Text] [Related]
17. Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?
Lee C; Tummon I; Martin J; Nisker J; Power S; Tekpetey F
Hum Reprod; 1998 May; 13(5):1157-8. PubMed ID: 9647538
[TBL] [Abstract][Full Text] [Related]
18. A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients.
Delvigne A; Rozenberg S
Hum Reprod Update; 2002; 8(3):291-6. PubMed ID: 12078839
[TBL] [Abstract][Full Text] [Related]
19. Withholding gonadotropins ("coasting") to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles.
Fluker MR; Hooper WM; Yuzpe AA
Fertil Steril; 1999 Feb; 71(2):294-301. PubMed ID: 9988401
[TBL] [Abstract][Full Text] [Related]
20. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
